Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
DI Velligan, M Sajatovic, A Hatch… - Patient preference …, 2017 - Taylor & Francis
Background Antipsychotic medication reduces the severity of serious mental illness (SMI)
and improves patient outcomes only when medicines were taken as prescribed …
and improves patient outcomes only when medicines were taken as prescribed …
[HTML][HTML] The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence
CU Correll, L Citrome, PM Haddad… - The Journal of clinical …, 2016 - psychiatrist.com
METHODS A group of 8 experts on the management of schizophrenia and LAIs met to
evaluate the evidence and to develop a set of recommendations regarding the clinical use …
evaluate the evidence and to develop a set of recommendations regarding the clinical use …
[图书][B] The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia
American Psychiatric Association - 2020 - books.google.com
The American Psychiatric Association Practice Guideline for the Treatment of Patients With
Schizophrenia seeks to reduce these substantial psychosocial and public health …
Schizophrenia seeks to reduce these substantial psychosocial and public health …
What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?
CU Correll, JM Rubio, JM Kane - World Psychiatry, 2018 - Wiley Online Library
The long‐term benefit‐to‐risk ratio of sustained antipsychotic treatment for schizophrenia
has recently been questioned. In this paper, we critically examine the literature on the long …
has recently been questioned. In this paper, we critically examine the literature on the long …
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies
PM Haddad, C Brain, J Scott - Patient related outcome measures, 2014 - Taylor & Francis
Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …
Non‐adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
JM Kane, T Kishimoto, CU Correll - World psychiatry, 2013 - Wiley Online Library
Although non‐adherence is common across all branches of medicine, psychotic disorders
pose additional challenges that increase its risk. Despite the importance of non‐adherence …
pose additional challenges that increase its risk. Despite the importance of non‐adherence …
Portraying mental illness and drug addiction as treatable health conditions: Effects of a randomized experiment on stigma and discrimination
EE McGinty, HH Goldman, B Pescosolido… - Social science & …, 2015 - Elsevier
Despite significant advances in treatment, stigma and discrimination toward persons with
mental illness and drug addiction have remained constant in past decades. Prior work …
mental illness and drug addiction have remained constant in past decades. Prior work …
Development and usability testing of FOCUS: a smartphone system for self-management of schizophrenia.
D Ben-Zeev, SM Kaiser, CJ Brenner… - Psychiatric …, 2013 - psycnet.apa.org
Objective: Mobile Health (mHealth) approaches can support the rehabilitation of individuals
with psychiatric conditions. In the current article, we describe the development of a …
with psychiatric conditions. In the current article, we describe the development of a …
[HTML][HTML] What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders
S Chakrabarti - World journal of psychiatry, 2014 - ncbi.nlm.nih.gov
About half or more of the patients with chronic psychiatric illnesses, either do not take their
medications correctly, or completely stop taking them. The problem of poor initial compliance …
medications correctly, or completely stop taking them. The problem of poor initial compliance …
Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia
D Novick, JM Haro, D Suarez, V Perez, RW Dittmann… - Psychiatry …, 2010 - Elsevier
To assess baseline predictors and consequences of antipsychotic adherence during long-
term treatment of schizophrenia outpatients, data were taken from the 3-year, prospective …
term treatment of schizophrenia outpatients, data were taken from the 3-year, prospective …